A. BENGTSSON: "The role of CD30 in atopic disease", ALLERGY, vol. 56, no. 7, 1 July 2001 (2001-07-01), pages 593-603, XP55074403, ISSN: 0105-4538, DOI: 10.1034/j.1398-9995.2001.00137.x (B1)

GIAGULLI CINZIA ET AL: "Pidotimod promotes functional maturation of dendritic cells and displays adjuvant properties at the nasal mucosa level.", INTERNATIONAL IMMUNOPHARMACOLOGY NOV 2009, vol. 9, no. 12, November 2009 (2009-11), pages 1366-1373, ISSN: 1878-1705 (B1)

GOURGIOTIS DIMITRIOS ET AL: "Immune modulator pidotimod decreases the in vitro expression of CD30 in peripheral blood mononuclear cells of atopic asthmatic and normal children", JOURNAL OF ASTHMA, ASTHMA PUBLICATIONS SOCIETY, OSSINING, NY, US, vol. 41, no. 3, 1 January 2004 (2004-01-01), pages 285-287, XP008164025, ISSN: 0277-0903, DOI: 10.1081/JAS-120026085 (B1)

TARAMELLI D ET AL: "Effects of pidotimod on macrophage functions in methylprednisolone-treated mice.", ARZNEIMITTEL-FORSCHUNG DEC 1994, vol. 44, no. 12A, December 1994 (1994-12), pages 1425-1430, ISSN: 0004-4172 (B1)

POZZI E ET AL: "Pidotimod in the treatment of patients affected by bacterial exacerbations of chronic bronchitis", 19940101, vol. 44, no. 12A, 1 January 1994 (1994-01-01), pages 1495-1498, XP008097244, (B1)

SIMHADRI VIJAYA LAKSHMI ET AL: "A novel role for reciprocal CD30-CD30L signaling in the cross-talk between natural killer and dendritic cells.", BIOLOGICAL CHEMISTRY JAN 2012, vol. 393, no. 1-2, January 2012 (2012-01), pages 101-106, ISSN: 1437-4315 (B1)

IT-B- 1 231 723 (B1)